LENVERVIMAB
UNII FX9X4L2A2L

Substance Identification & Data

This profile provides standardized clinical and technical data for Lenvervimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) FX9X4L2A2L.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2055006-79-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

FX9X4L2A2L

CAS Registry Number

2055006-79-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LENVERVIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C170106

National Cancer Institute reference terminology for clinical and research data.

INN ID

10746

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lenvervimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LENVERVIMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HEPATITIS B SURFACE ANTIGEN) (HUMAN MONOCLONAL GC1102 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL GC1102 .KAPPA.-CHAIN, DIMER

LENVERVIMAB [INN]